- Home
- CLDI vs EKSO Comparison
CLDI vs EKSO Comparison
Compare CLDI & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- EKSO
- Stock Information
- Founded
- CLDI 2014
- EKSO 2005
- Country
- CLDI United States
- EKSO United States
- Employees
- CLDI N/A
- EKSO N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- EKSO Medical/Dental Instruments
- Sector
- CLDI Health Care
- EKSO Health Care
- Exchange
- CLDI Nasdaq
- EKSO Nasdaq
- Market Cap
- CLDI 12.0M
- EKSO 11.7M
- IPO Year
- CLDI N/A
- EKSO N/A
- Fundamental
- Price
- CLDI $0.36
- EKSO $4.27
- Analyst Decision
- CLDI Strong Buy
- EKSO Strong Buy
- Analyst Count
- CLDI 1
- EKSO 2
- Target Price
- CLDI $10.00
- EKSO $37.50
- AVG Volume (30 Days)
- CLDI 456.3K
- EKSO 440.1K
- Earning Date
- CLDI 05-14-2025
- EKSO 07-28-2025
- Dividend Yield
- CLDI N/A
- EKSO N/A
- EPS Growth
- CLDI N/A
- EKSO N/A
- EPS
- CLDI N/A
- EKSO N/A
- Revenue
- CLDI N/A
- EKSO $17,544,000.00
- Revenue This Year
- CLDI N/A
- EKSO $0.20
- Revenue Next Year
- CLDI N/A
- EKSO $42.29
- P/E Ratio
- CLDI N/A
- EKSO N/A
- Revenue Growth
- CLDI N/A
- EKSO N/A
- 52 Week Low
- CLDI $0.34
- EKSO $3.46
- 52 Week High
- CLDI $3.89
- EKSO $22.95
- Technical
- Relative Strength Index (RSI)
- CLDI 34.85
- EKSO 34.34
- Support Level
- CLDI $0.34
- EKSO $4.12
- Resistance Level
- CLDI $0.39
- EKSO $4.99
- Average True Range (ATR)
- CLDI 0.04
- EKSO 0.58
- MACD
- CLDI 0.00
- EKSO -0.00
- Stochastic Oscillator
- CLDI 15.45
- EKSO 36.02
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.